News | June 04, 2014

New Performance Metrics for Cath PCI Accreditation Published by Accreditation for Cardiovascular Excellence

New performance metrics support quality standards for interventional cardiology best practices

June 4, 2014 — The Accreditation for Cardiovascular Excellence (ACE) Board of Directors has approved a new set of Performance Metrics for Cath PCI Accreditation. These metrics have been published and are now available for download on the ACE website or are available in hard copy.

ACE updated its Cath/PCI performance metrics to align with the NCDR CathPCI Registry, NCDR ACTION Registry and the Hospital Compare data. Thirty-six performance metrics in PCI, Diagnostic Cath, STEMI/NSTEMI and Medicare Hospital Compare Outcomes have been updated.

"It is critically important to align performance metrics with cath lab documentation," said Gregory J. Dehmer, M.D., FACC, FACP, FAHA, FSCAI and ACE board chair. "Incorporating these performance metrics into the ACE accreditation program maintains best practices for interventional cardiology."

SCAI 2013-14 President Ted A. Bass, M.D., FSCAI, is a long-time advocate of efforts, such as ACE's, that promote adherence to quality standards in cardiac cath labs. "I am excited by the rapidly growing number of cath labs that are applying for ACE review and accreditation," said Bass. "Cath lab accreditation is becoming a must-have for interventional cardiology labs."

For more information: www.cvexcel.org

Related Content

Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Serial coronary angiograms of the representative case treated with shockwave intravascular lithotripsy.

Figure 1. Serial coronary angiograms of the representative case treated with shockwave intravascular lithotripsy.

Feature | Cath Lab | April 16, 2018 | Azeem Latib, M.D.
Over the last decade, there have been considerable developments in procedural techniques and technology facilitating
Overlay Init